Nordic Life Science 1
Terje Straume, Global Head Healthcare, DNB Bank,
Lotta Ljungqvist, President & CEO, GE Nordics and CEO, Testa Center at GE Healthcare, Helena Strigård, Director General, SwedenBIO and Peter Albiez, Country Manager, Pfizer Germany Centre Leman, shortly based at AGORA, in Lausanne, explore cutting edge therapeutic strategies for cancer. The interdisciplinary, multi-institutional building houses competencies also from other fields. He emphasized the importance of collaborating with a clinic. The development of new advanced therapies and precision diagnostics demands a close collaboration between the clinic and research. This seventh NLSDays event united 1240 delegates from a record number of organizations across the global life science industry, according to SwedenBIO. This year also saw an extended first day with a number of satellite events, including educational sessions on clinical development, funding for SMEs, and advancing ATMPs into the clinic. There was also a series of pitches to showcase the best of Swedish and Danish life science from Medicon Valley. The event featured 46 company presentations with updates from organizations of all sizes, and 2750 partnering meetings for delegates throughout the event. “We would like to thank our regional co-hosts, our Nordic consortium partners, sponsors, exhibitions, presenters, speakers and delegates for making this such a great event. We are also happy to be back in Malmö for the next two upcoming years. This is really a hotbed for life science and business partnerships. See you again next year on September 8–10!” said Olivier Duchamp, Managing Director, NLSDays. NLS 110 Malin Otmani, Editor in Chief, Nordic Life Science and Sara Lundquist, Project communicator, RISE The team from Fujifilm